Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Mustang Bio
MBIO
$4.59M
| $3.62M | ﹤0.01% |
1,795
+183
| +11% | +$393K |
|
|
LONA
3102
LeonaBio Inc
LONA
$73.9M
| $3.62M | ﹤0.01% |
38,575
-2,454
| -6% | -$250K |
|
|
XOMA
3103
DELISTED
Xoma
XOMA
| $3.62M | ﹤0.01% |
146,218
+5,951
| +4% | +$175K |
|
|
ITI
3104
DELISTED
Iteris, Inc.
ITI
| $3.61M | ﹤0.01% |
684,149
+7,869
| +1% | +$46K |
|
3105
Nature's Sunshine
NATR
$273M
| $3.61M | ﹤0.01% |
246,362
-4,350
| -2% | -$73K |
|
3106
EyePoint Inc
EYPT
$1.16B
| $3.59M | ﹤0.01% |
344,153
+11,663
| +4% | +$111K |
|
|
PVLA
3107
Palvella Therapeutics
PVLA
$2.23B
| $3.59M | ﹤0.01% |
8,671
+1,516
| +21% | +$528K |
|
|
DS
3108
DELISTED
Drive Shack Inc.
DS
| $3.58M | ﹤0.01% |
1,273,966
-22,820
| -2% | -$61.4K |
|
3109
Root
ROOT
$748M
| $3.57M | ﹤0.01% |
37,634
+7,146
| +23% | +$886K |
|
|
MKFG
3110
DELISTED
Markforged Holding Corporation
MKFG
| $3.56M | ﹤0.01% |
+54,240
| New | +$4.83M |
|
3111
Adecoagro
AGRO
$1.31B
| $3.54M | ﹤0.01% |
395,741
+63,450
| +19% | +$596K |
|
3112
Petrobras
PBR
$115B
| $3.54M | ﹤0.01% |
342,140
-29,839
| -8% | -$318K |
|
3113
Pearson
PSO
$9.7B
| $3.54M | ﹤0.01% |
365,862
-377
| -0.1% | -$4.09K |
|
|
FTSI
3114
DELISTED
FTS International, Inc. Common Stock
FTSI
| $3.53M | ﹤0.01% |
143,364
+2,216
| +2% | +$50.6K |
|
|
VINC
3115
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $3.52M | ﹤0.01% |
10,890
+3,351
| +44% | +$978K |
|
3116
Mirum Pharmaceuticals
MIRM
$6.02B
| $3.52M | ﹤0.01% |
176,673
+2,402
| +1% | +$39.1K |
|
|
SLCT
3117
DELISTED
Select Bancorp, Inc.
SLCT
| $3.52M | ﹤0.01% |
203,930
+5,650
| +3% | +$91.2K |
|
3118
Cadiz
CDZI
$292M
| $3.51M | ﹤0.01% |
499,016
+20,025
| +4% | +$246K |
|
3119
UBS Group
UBS
$176B
| $3.51M | ﹤0.01% |
220,139
-37,388
| -15% | -$606K |
|
|
LTRPA
3120
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $3.5M | ﹤0.01% |
1,133,491
-99,576
| -8% | -$371K |
|
|
HMTV
3121
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $3.5M | ﹤0.01% |
287,316
+4,412
| +2% | +$53.7K |
|
|
BRG
3122
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $3.5M | ﹤0.01% |
274,492
+17,073
| +7% | +$198K |
|
3123
Concrete Pumping Holdings
BBCP
$479M
| $3.49M | ﹤0.01% |
409,095
+3,596
| +0.9% | +$30.2K |
|
|
ETNB
3124
DELISTED
89bio
ETNB
| $3.49M | ﹤0.01% |
178,325
+21,057
| +13% | +$385K |
|
|
FRGI
3125
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $3.49M | ﹤0.01% |
318,713
+6,803
| +2% | +$85.5K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.